Literature DB >> 22146989

Gender distribution of serum uric acid and cardiovascular risk factors: population based study.

Sérgio Lamego Rodrigues1, Marcelo Perim Baldo, Pires Capingana, Pedro Magalhães, Eduardo Miranda Dantas, Maria del Carmen Bisi Molina, Luciane Bresciani Salaroli, Renato Lário Morelato, José Geraldo Mill.   

Abstract

BACKGROUND: There is no data concerning the epidemiology of hyperuricemia in Brazilian population-based studies.
OBJECTIVE: To investigate the distribution of serum uric acid and its relationship with demographics and cardiovascular variables.
METHODS: We studied 1,346 individuals. Hyperuricemia was defined as ≥ 6.8 and ≥ 5.4 mg/dL for men and women, respectively. Metabolic syndrome (MS) was defined with NCEP ATP III criteria.
RESULTS: The prevalence of hyperuricemia was 13.2%. The association of serum uric acid (SUA) with cardiovascular risk factors was gender-specific: in women, higher SUA was associated with increasing BMI, even after adjustments for age-systolic blood pressure (SBP). In men, the relationship of SUA with HDLc was mediated by BMI, whereas in women, SUA was similar and dependent on BMI, regardless of glucose levels and presence of hypertension. In men, triglycerides, waist circumference (WC) and SBP explained 11%, 4% and 1% of SUA variability, respectively. In women, WC and triglycerides explained 9% and 1% of SUA variability, respectively. Compared to the first quartile, men and women in the fourth quartile had a 3.29 fold and 4.18 fold increase of MS risk, respectively. Women had almost three fold higher prevalence of diabetes mellitus. Normotensive men with MS presented higher SUA, regardless of BMI.
CONCLUSION: Our results seem to justify the need for gender-based evaluation regarding the association of SUA with cardiovascular risk factors, which was more pronounced in women. MS was positively associated with increasing SUA, regardless of gender. Abdominal obesity and hypertriglyceridemia were the main factors associated with hyperuricemia even in normotensive individuals, which may add a higher risk for hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22146989     DOI: 10.1590/s0066-782x2011005000116

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  23 in total

1.  Effects of serum uric acid levels on the arginase pathway in women with metabolic syndrome.

Authors:  S Uslu; E Ozcelik; N Kebapci; H E Temel; F Demirci; B Ergun; C Demirustu
Journal:  Ir J Med Sci       Date:  2015-08-02       Impact factor: 1.568

2.  Polymorphisms in the vitamin D receptor and risk of gout in Chinese Han male population.

Authors:  Shi-guo Liu; Yuan-yuan Li; Rui-xia Sun; Jing-li Wang; Xin-de Li; Lin Han; Nan Chu; Chang-gui Li
Journal:  Rheumatol Int       Date:  2014-11-07       Impact factor: 2.631

3.  Reference range of serum uric acid and prevalence of hyperuricemia: a cross-sectional study from baseline data of ELSA-Brasil cohort.

Authors:  Murillo Dório; Isabela M Benseñor; Paulo Lotufo; Itamar S Santos; Ricardo Fuller
Journal:  Adv Rheumatol       Date:  2022-05-08

Review 4.  Hyperuricemia and cardiovascular risk.

Authors:  Davide Grassi; Giovambattista Desideri; Anna Vittoria Di Giacomantonio; Paolo Di Giosia; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-02-20

5.  Distribution of Serum Uric Acid in Black Africans and Its Association With Cardiovascular Risk Factors.

Authors:  Stephanie R Moulin; Marcelo P Baldo; Juliana B Souza; Weverton M Luchi; Daniel P Capingana; Pedro Magalhães; José G Mill
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-30       Impact factor: 3.738

6.  Salivary uric acid as a noninvasive biomarker of metabolic syndrome.

Authors:  Maria Soukup; Izabela Biesiada; Aaron Henderson; Benmichael Idowu; Derek Rodeback; Lance Ridpath; Edward G Bridges; Andrea M Nazar; Kristie Grove Bridges
Journal:  Diabetol Metab Syndr       Date:  2012-04-19       Impact factor: 3.320

7.  Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?

Authors:  Rezvan Salehidoost; Ashraf Aminorroaya; Maryam Zare; Massoud Amini
Journal:  J Res Med Sci       Date:  2012-11       Impact factor: 1.852

8.  Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis.

Authors:  Xueping Chen; Xiaoyan Guo; Rui Huang; Yongping Chen; Zhenzhen Zheng; Huifang Shang
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

9.  Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in taiwan.

Authors:  Hung-Yu Chang; Pei-Hsien Lee; Chen-Chou Lei; Chun-Wu Tung; Yung-Chien Hsu; Tung-Jung Huang; Long-Chuan Lu; Chun-Liang Lin
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

10.  Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations.

Authors:  Filipa Mascarenhas-Melo; José Sereno; Edite Teixeira-Lemos; Sandra Ribeiro; Petronila Rocha-Pereira; Ethan Cotterill; Frederico Teixeira; Flávio Reis
Journal:  Dis Markers       Date:  2013-07-28       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.